Aspen Aerogels (NYSE:ASPN) Cut to Sell at Wall Street Zen

Wall Street Zen lowered shares of Aspen Aerogels (NYSE:ASPNFree Report) from a hold rating to a sell rating in a research note released on Saturday morning.

Several other research firms also recently commented on ASPN. B. Riley Financial restated a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital reiterated a “buy” rating and issued a $7.75 price objective on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays lifted their target price on Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Tuesday, August 11th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels presently has an average rating of “Hold” and a consensus price target of $5.94.

Read Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Stock Down 0.3%

Shares of ASPN opened at $5.83 on Friday. The company’s 50-day simple moving average is $5.52 and its 200-day simple moving average is $4.53. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.35. The stock has a market capitalization of $483.83 million, a PE ratio of -3.81 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The firm had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Analysts forecast that Aspen Aerogels will post -0.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rice Hall James & Associates LLC lifted its position in shares of Aspen Aerogels by 9.2% during the 1st quarter. Rice Hall James & Associates LLC now owns 1,552,628 shares of the construction company’s stock worth $5,310,000 after purchasing an additional 131,023 shares during the last quarter. Needham Investment Management LLC increased its holdings in Aspen Aerogels by 26.5% in the fourth quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after buying an additional 912,000 shares during the last quarter. Lazard Asset Management LLC purchased a new position in Aspen Aerogels in the first quarter valued at $485,000. First Eagle Investment Management LLC raised its stake in Aspen Aerogels by 20.3% in the fourth quarter. First Eagle Investment Management LLC now owns 622,487 shares of the construction company’s stock valued at $1,762,000 after buying an additional 105,164 shares in the last quarter. Finally, Connors Investor Services Inc. raised its stake in Aspen Aerogels by 37.3% in the fourth quarter. Connors Investor Services Inc. now owns 55,167 shares of the construction company’s stock valued at $156,000 after buying an additional 15,000 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Read More

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.